Absci Corp
Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to design differentiated antibody therapeutics. Its preclinical development programs include ABS-101 for the treatment of inflammatory bowel disease; ABS-201 for treating androgenic alopecia; ABS-301 for the treat… Read more
Absci Corp (ABSI) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.119x
Based on the latest financial reports, Absci Corp (ABSI) has a cash flow conversion efficiency ratio of -0.119x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-25.03 Million) by net assets ($210.34 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Absci Corp - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how Absci Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Absci Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Absci Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SAMPYO Cement Co. Ltd
KQ:038500
|
0.061x |
|
Maxvision Technology Corp
SHE:002990
|
0.032x |
|
Nu Skin Enterprises Inc
NYSE:NUS
|
0.034x |
|
CICOR TECHNOL.NAM. SF 10
F:CRLN
|
0.194x |
|
Wenzhou Hongfeng Electrical Alloy Co Ltd
SHE:300283
|
0.047x |
|
Beijing Kawin Technology Share-holding Co Ltd
SHG:688687
|
0.014x |
|
Hotai Finance Corp
TW:6592
|
-0.014x |
|
Beijing Hanyi Innovation Technology Co. Ltd. A
SHE:301270
|
N/A |
Annual Cash Flow Conversion Efficiency for Absci Corp (2019–2024)
The table below shows the annual cash flow conversion efficiency of Absci Corp from 2019 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $179.13 Million | $-72.40 Million | -0.404x | -10.17% |
| 2023-12-31 | $176.18 Million | $-64.64 Million | -0.367x | -23.78% |
| 2022-12-31 | $274.41 Million | $-81.34 Million | -0.296x | -79.08% |
| 2021-12-31 | $366.11 Million | $-60.60 Million | -0.166x | -1.10% |
| 2020-12-31 | $67.00 Million | $-10.97 Million | -0.164x | -211.71% |
| 2019-12-31 | $-41.16 Million | $-6.03 Million | 0.147x | -- |